Position in ZTS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$96,004
+$83,001 QoQ
Shares Held
1,336
+1114.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,104
of 1,414 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $6,303,747 across 20 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
229,137 | $5,639,061 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
345 | $186,931 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
10,019 | $173,428 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
1,336 | $96,004 | |
| 5 | VTRS |
Viatris Inc
|
4,335 | $68,839 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
283 | $47,696 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,562 | $41,068 | |
| 8 | HLN |
Haleon plc
|
4,174 | $38,943 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,004 | 1,336 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $13,003 | 110 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,211 | 105 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,777 | 142 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,072 | 71 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,794 | 102 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,461 | 144 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,361,076 | 22,321 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,156,652 | 23,977 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,057,148 | 23,977 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,900,870 | 9,631 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,803,824 | 10,368 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,178,112 | 12,648 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,068,017 | 12,425 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $961,954 | 6,564 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,037,585 | 6,997 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $871,997 | 5,073 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $1,304 | 7 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,574 | 10 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,986 | 12 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,984 | 12 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,697,065 | 26,978 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $588 | 5 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||